Botswana vs Norway: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Botswana
95.0%
in 2025
Norway
95.0%
in 2025
Botswana rank
38th
Norway rank
38th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Botswana
- Norway
How they compare
Botswana currently reports 95.0% against 95.0% in Norway, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Norway ahead.
Botswana ranks 38th and Norway ranks 38th of 194 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Botswana | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 88.5% | 88.5% | Norway |
| 2010s | 66.8% | 93.0% | 26.2% | Norway |
| 2020s | 88.8% | 95.3% | 6.5% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Botswana or Norway?
- Botswana, at 95.0% against 95.0% in Norway as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Botswana and Norway?
- 0.0%, with Botswana ahead.
- How many years of comparable data are there for Botswana and Norway?
- 18 years are reported by both, from 2008 to 2025.
- How do Botswana and Norway rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Botswana ranks 38th and Norway ranks 38th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.